These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30959762)

  • 21. Validation of two fluoro-analogues of N,N-dimethyl-2-(2'-amino-4'-hydroxymethyl-phenylthio)benzylamine as serotonin transporter imaging agents using microPET.
    Jarkas N; Voll RJ; Williams L; Goodman MM
    Nucl Med Biol; 2010 Jul; 37(5):593-603. PubMed ID: 20610164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [11C]-DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats.
    Ginovart N; Wilson AA; Meyer JH; Hussey D; Houle S
    Synapse; 2003 Feb; 47(2):123-33. PubMed ID: 12454950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and characterization of EADAM: a selective radioligand for mapping the brain serotonin transporters by positron emission tomography.
    Jarkas N; McConathy J; Votaw JR; Voll RJ; Malveaux E; Camp VM; Williams L; Goodman RR; Kilts CD; Goodman MM
    Nucl Med Biol; 2005 Jan; 32(1):75-86. PubMed ID: 15691664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo characterization of a series of 18F-diaryl sulfides (18F-2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)phenylthio)benzenamine) for PET imaging of the serotonin transporter.
    Wang JL; Parhi AK; Oya S; Lieberman B; Kung HF
    J Nucl Med; 2009 Sep; 50(9):1509-17. PubMed ID: 19690040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study.
    Klein N; Sacher J; Geiss-Granadia T; Mossaheb N; Attarbaschi T; Lanzenberger R; Spindelegger C; Holik A; Asenbaum S; Dudczak R; Tauscher J; Kasper S
    Psychopharmacology (Berl); 2007 Apr; 191(2):333-9. PubMed ID: 17235610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional differences in SERT occupancy after acute and prolonged SSRI intake investigated by brain PET.
    Baldinger P; Kranz GS; Haeusler D; Savli M; Spies M; Philippe C; Hahn A; Höflich A; Wadsak W; Mitterhauser M; Lanzenberger R; Kasper S
    Neuroimage; 2014 Mar; 88():252-62. PubMed ID: 24121201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (11) C and (18) F PET radioligands for the serotonin transporter (SERT).
    Stehouwer JS; Goodman MM
    J Labelled Comp Radiopharm; 2013; 56(3-4):114-9. PubMed ID: 24285317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo studies of the SERT-selective [18F]FPBM and VMAT2-selective [18F]AV-133 radiotracers in a rat model of Parkinson's disease.
    Wang JL; Oya S; Parhi AK; Lieberman BP; Ploessl K; Hou C; Kung HF
    Nucl Med Biol; 2010 May; 37(4):479-86. PubMed ID: 20447560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Displacement of serotonin and dopamine transporters by venlafaxine extended release capsule at steady state: a [123I]2beta-carbomethoxy-3beta-(4-iodophenyl)-tropane single photon emission computed tomography imaging study.
    Shang Y; Gibbs MA; Marek GJ; Stiger T; Burstein AH; Marek K; Seibyl JP; Rogers JF
    J Clin Psychopharmacol; 2007 Feb; 27(1):71-5. PubMed ID: 17224717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [11C]SMe-ADAM, an imaging agent for the brain serotonin transporter: synthesis, pharmacological characterization and microPET studies in rats.
    Zessin J; Deuther-Conrad W; Kretzschmar M; Wüst F; Pawelke B; Brust P; Steinbach J; Bergmann R
    Nucl Med Biol; 2006 Jan; 33(1):53-63. PubMed ID: 16459259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in thalamus-hypothalamus serotonin transporter availability during clomipramine administration in patients with obsessive-compulsive disorder.
    Zitterl W; Aigner M; Stompe T; Zitterl-Eglseer K; Gutierrez-Lobos K; Wenzel T; Zettinig G; Hornik K; Pirker W; Thau K
    Neuropsychopharmacology; 2008 Dec; 33(13):3126-34. PubMed ID: 18354388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new positron emission tomography imaging agent for the serotonin transporter: synthesis, pharmacological characterization, and kinetic analysis of [11C]2-[2-(dimethylaminomethyl)phenylthio]-5-fluoromethylphenylamine ([11C]AFM).
    Huang Y; Hwang DR; Bae SA; Sudo Y; Guo N; Zhu Z; Narendran R; Laruelle M
    Nucl Med Biol; 2004 Jul; 31(5):543-56. PubMed ID: 15219271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo long-lasting alterations of central serotonin transporter activity and associated dopamine synthesis after acute repeated administration of methamphetamine.
    Huang WS; Chen GJ; Tsai TH; Cheng CY; Shiue CY; Ma KH; Yeh SH
    EJNMMI Res; 2019 Sep; 9(1):92. PubMed ID: 31535286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. S-[18F]fluoromethyl-(+)-McN5652, a PET tracer for the serotonin transporter: evaluation in rats.
    Marjamäki P; Zessin J; Eskola O; Grönroos T; Haaparanta M; Bergman J; Lehikoinen P; Forsback S; Brust P; Steinbach J; Solin O
    Synapse; 2003 Jan; 47(1):45-53. PubMed ID: 12422372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amitriptyline Accelerates SERT Binding Recovery in a Rat 3,4-Methylenedioxymethamphetamine (MDMA) Model: In Vivo 4-[
    Tsai CJ; Chiu CH; Kuo YY; Huang WS; Yu TH; Flores LG; Yeh SH; Ma KH
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of FlipIDAM as a SERT-selective SPECT imaging agent.
    Lemoine L; Lieberman BP; Ploessl K; Zheng P; Kung HF
    Nucl Med Biol; 2013 Oct; 40(7):879-86. PubMed ID: 23856117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histamine Receptors Regulate the Activity, Surface Expression, and Phosphorylation of Serotonin Transporters.
    Annamalai B; Ragu Varman D; Horton RE; Daws LC; Jayanthi LD; Ramamoorthy S
    ACS Chem Neurosci; 2020 Feb; 11(3):466-476. PubMed ID: 31916747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incongruent reduction of serotonin transporter associated with suicide attempts in patients with major depressive disorder: a positron emission tomography study with 4-[18F]-ADAM.
    Yeh YW; Ho PS; Chen CY; Kuo SC; Liang CS; Ma KH; Shiue CY; Huang WS; Cheng CY; Wang TY; Lu RB; Huang SY
    Int J Neuropsychopharmacol; 2014 Oct; 18(3):. PubMed ID: 25522405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autophagy inhibition plays a protective role against 3, 4-methylenedioxymethamphetamine (MDMA)-induced loss of serotonin transporters and depressive-like behaviors in rats.
    Shih JH; Chiu CH; Ma KH; Huang YS; Shiue CY; Yeh TY; Kao LT; Lin YY; Li IH
    Pharmacol Res; 2019 Apr; 142():283-293. PubMed ID: 30826457
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.